(2)The approval period of the active substance flutriafol was extended from 31 May 2021 until 31 May 2024 by Commission Implementing Regulation (EU) 2018/1266note and additionally until 31 August 2024 by Commission Implementing Regulation (EU) 2020/2007note. The approval period of the active substance Adoxophyes orana granulovirus was extended from 31 January 2023 until 31 January 2024 by Implementing Regulation (EU) 2020/2007.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.